SCHEMBL8429673

SCHEMBL8429673

CCc1ccc(F)c2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DAO P14920 2/20 0.46
FFAR1 O14842 1/20 0.43
MAPT P10636 2/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CNR2 P34972 6/20 0.39
CNR1 P21554 4/20 0.39
NPBWR1 P48145 1/20 0.38
SLC6A4 P31645 3/20 0.38
SLC6A3 Q01959 3/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
ALDH1A1 P00352 1/20 0.36
TSHR P16473 1/20 0.36
SIGMAR1 Q99720 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20012574 0.86 DAO (0.46) DAOLMNAHPGDHTTALDH1A1
SCHEMBL5682891 0.85 GABRA1 (0.43) HTTCNR2ALDH1A1
SCHEMBL30537735 0.85 GABRA1 (0.43) HTTCNR2ALDH1A1
SCHEMBL15352024 0.82 DAO (0.46) DAOFFAR1MAPTLMNAHPGD
SCHEMBL30975082 0.79 DAO (0.44) DAOFFAR1MAPTLMNAHPGD
SCHEMBL1229631 0.79 DAO (0.44) DAOFFAR1MAPTLMNAHPGD
SCHEMBL29352142 0.78 CNR2 (0.39) MAPTLMNACNR2CNR1SMN1; SMN2
SCHEMBL8851691 0.78 DAO (0.38) DAOFFAR1MAPTLMNAHPGD
SCHEMBL8851694 0.78 HPGD (0.41) DAOFFAR1MAPTLMNAHPGD
SCHEMBL5239308 0.78 FFAR1 (0.41) DAOFFAR1MAPTLMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230374036-A1 KRAS G12D MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2023-11-23 US disclosed
US-20230339981-A1 KRAS G12D MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2023-10-26 US disclosed
US-11746116-B2 Antibiotic resistance breakers KING'S COLLEGE LONDON (GB) 2023-09-05 US disclosed
EP-3943500-A1 PHOSPHOROUS PROTECTING GROUPS AND METHODS OF PREPARATION AND USE THEREOF Agilent Technologies, Inc. (US) 2022-01-26 EP disclosed
US-20220020935-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES Beijing Summer Sprout Technology Co., Ltd. (CN) 2022-01-20 US disclosed
EP-3137478-B1 PHOSPHOROUS PROTECTING GROUPS AND METHODS OF PREPARATION AND USE THEREOF AGILENT TECHNOLOGIES INC (US) 2021-09-22 EP disclosed
US-10807968-B2 Substituted 2-(het)arylimidazolylcarboxyamides as pesticides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-10-20 US disclosed
US-20200048221-A1 SUBSTITUTED 2-(HET)ARYLIMIDAZOLYLCARBOXYAMIDES AS PESTICIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-02-13 US disclosed
US-10544124-B2 Substituted 2-(het)arylimidazolylcarboxyamides as pesticides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-01-28 US disclosed
US-10280149-B2 Therapeutic compounds and uses thereof GENENTECH, INC. (US) 2019-05-07 US disclosed
US-20190047982-A1 Substituted 2-(het)arylimidazolylcarboxyamides as pesticides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-02-14 US disclosed
WO-2018057805-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS GILEAD SCIENCES, INC. (US) 2018-03-29 WO disclosed
US-20180022727-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2018-01-25 US disclosed
US-20150315227-A1 PHOSPHOROUS PROTECTING GROUPS AND METHODS OF PREPARATION AND USE THEREOF UNIVERSITY OF COLORADO BOULDER 2015-11-05 US disclosed
WO-2015168461-A2 PHOSPHOROUS PROTECTING GROUPS AND METHODS OF PREPARATION AND USE THEREOF AGILENT TECHNOLOGIES, INC. (US) 2015-11-05 WO disclosed
EP-2341044-B1 CYCLOALKYLAMINE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2014-02-26 EP disclosed
US-8226966-B2 Fungicide N-6-membered fused (hetero) aryl-methylene-N-cycloalkyl carboxamide derivatives BAYER CROPSCIENCE AG (DE) 2012-07-24 US disclosed
US-20100144785-A1 FUNGICIDE N-6-MEMBERED FUSED (HETERO) ARYL-METHYLENE-N-CYCLOALKYL CARBOXAMIDE DERIVATIVES BAYER SAS (FR) 2010-06-10 US disclosed
US-20070072859-A1 Pharmaceutical compounds ELI LILLY AND COMPANY (US) 2007-03-29 US disclosed
US-20040082578-A1 Arylindenopyridines and related therapeutic and prophylactic methods ORTHO-MCNEIL PHARMACEUTICAL, INC. 2004-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (14 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190047982-A1 Substituted 2-(het)arylimidazolylcarboxyamides as pesticides DDT, CYP4X1, CYP4Z1 DAO 219/4885FFAR1 2418/4885MAPT 4737/4885
US-20200048221-A1 SUBSTITUTED 2-(HET)ARYLIMIDAZOLYLCARBOXYAMIDES AS PESTICIDES DDT, CYP4X1, CYP4Z1 DAO 219/4885FFAR1 2418/4885MAPT 4737/4885
US-20040082578-A1 Arylindenopyridines and related therapeutic and prophylactic methods ADORA2A, ADORA1, PDE2A DAO 1870/4885FFAR1 276/4885MAPT 4577/4885
US-10807968-B2 Substituted 2-(het)arylimidazolylcarboxyamides as pesticides DDT, CYP4X1, CYP4Z1 DAO 219/4885FFAR1 2418/4885MAPT 4737/4885
US-11746116-B2 Antibiotic resistance breakers ABCC1, ARL1, AKR1C3 DAO 1815/4885FFAR1 646/4885MAPT 1824/4885
US-10280149-B2 Therapeutic compounds and uses thereof KDM1B, KDM6B, KDM2B DAO 3792/4885FFAR1 3238/4885MAPT 1631/4885
US-20070072859-A1 Pharmaceutical compounds ADRB3, HTR3C, SLC6A2 DAO 1309/4885FFAR1 1076/4885MAPT 3717/4885
US-20150315227-A1 PHOSPHOROUS PROTECTING GROUPS AND METHODS OF PREPARATION AND USE THEREOF POLN, POLRMT, NUDT21 DAO 713/4885FFAR1 4683/4885MAPT 4148/4885
US-20230339981-A1 KRAS G12D MODULATING COMPOUNDS KRAS, NRAS, HRAS DAO 4809/4885FFAR1 4016/4885MAPT 3007/4885
US-20230374036-A1 KRAS G12D MODULATING COMPOUNDS KRAS, NRAS, HRAS DAO 4809/4885FFAR1 4016/4885MAPT 3007/4885
US-20180022727-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF KDM1B, KDM6B, KDM2B DAO 3792/4885FFAR1 3238/4885MAPT 1631/4885
US-20100144785-A1 FUNGICIDE N-6-MEMBERED FUSED (HETERO) ARYL-METHYLENE-N-CYCLOALKYL CARBOXAMIDE DERIVATIVES CBR3, NRDC, CBR1 DAO 747/4885FFAR1 1455/4885MAPT 3466/4885
US-10544124-B2 Substituted 2-(het)arylimidazolylcarboxyamides as pesticides DDT, CYP4X1, CYP4Z1 DAO 219/4885FFAR1 2418/4885MAPT 4737/4885
US-20220020935-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, LEF1 DAO 4660/4885FFAR1 2068/4885MAPT 454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.